Biomolecules (Dec 2021)

Do Epstein–Barr Virus Mutations and Natural Genome Sequence Variations Contribute to Disease?

  • Paul J. Farrell,
  • Robert E. White

DOI
https://doi.org/10.3390/biom12010017
Journal volume & issue
Vol. 12, no. 1
p. 17

Abstract

Read online

Most of the world’s population is infected by the Epstein–Barr virus (EBV), but the incidence of the diseases associated with EBV infection differs greatly in different parts of the world. Many factors may determine those differences, but variation in the virus genome is likely to be a contributing factor for some of the diseases. Here, we describe the main forms of EBV genome sequence variation, and the mechanisms by which variations in the virus genome are likely to contribute to disease. EBV genome deletions or polymorphisms can also provide useful markers for monitoring disease. If some EBV strains prove to be more pathogenic than others, this suggests the possible value of immunising people against infection by those pathogenic strains.

Keywords